Does FLECAINIDE Cause Interstitial lung disease? 83 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Interstitial lung disease have been filed in association with FLECAINIDE (Flecainide Acetate). This represents 1.9% of all adverse event reports for FLECAINIDE.
83
Reports of Interstitial lung disease with FLECAINIDE
1.9%
of all FLECAINIDE reports
3
Deaths
70
Hospitalizations
How Dangerous Is Interstitial lung disease From FLECAINIDE?
Of the 83 reports, 3 (3.6%) resulted in death, 70 (84.3%) required hospitalization, and 11 (13.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLECAINIDE. However, 83 reports have been filed with the FAERS database.
What Other Side Effects Does FLECAINIDE Cause?
Toxicity to various agents (676)
Drug ineffective (437)
Bradycardia (327)
Electrocardiogram qrs complex prolonged (324)
Hypotension (299)
Atrial fibrillation (278)
Electrocardiogram qt prolonged (258)
Cardiac arrest (252)
Completed suicide (223)
Ventricular tachycardia (221)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which FLECAINIDE Alternatives Have Lower Interstitial lung disease Risk?
FLECAINIDE vs FLIBANSERIN
FLECAINIDE vs FLOLAN
FLECAINIDE vs FLUCICLOVINE F-18
FLECAINIDE vs FLUCLOXACILLIN
FLECAINIDE vs FLUCONAZOLE